Safety and Metabolic Effects of Tesamorelin Evaluated in Patients with Type 2 Diabetes | RemedyX Labs Research Library

A research summary of Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial, examining safety and metabolic effects of tesamorelin evaluated in patients with type 2 diabetes. Cited source and RUO context from RemedyX Labs.